In March 2025, the company introduced new designs to get a direct-to-purchaser supplying of its Wegovy weight loss drug. The company established a new pharmacy, named NovoCare, which would demand prospects $499 per month for usage of the drug, less than fifty percent the expense of the drug by means of other pharmaceutical distribution networks.[53